Australia · Delayed Price · Currency is AUD Pro Medicus Statistics
Total Valuation
Pro Medicus has a market cap or net worth of AUD 28.15 billion. The enterprise value is 27.94 billion.
| Market Cap | 28.15B |
| Enterprise Value | 27.94B |
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | Sep 3, 2025 |
Share Statistics
Pro Medicus has 104.51 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 104.51M |
| Shares Outstanding | 104.51M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 48.64% |
| Owned by Institutions (%) | 14.66% |
| Float | 53.09M |
Valuation Ratios
The trailing PE ratio is 244.60 and the forward PE ratio is 177.98. Pro Medicus's PEG ratio is 4.71.
| PE Ratio | 244.60 |
| Forward PE | 177.98 |
| PS Ratio | 132.15 |
| PB Ratio | 109.53 |
| P/TBV Ratio | 119.16 |
| P/FCF Ratio | 253.81 |
| P/OCF Ratio | 252.81 |
| PEG Ratio | 4.71 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 175.95, with an EV/FCF ratio of 251.93.
| EV / Earnings | 242.48 |
| EV / Sales | 131.17 |
| EV / EBITDA | 175.95 |
| EV / EBIT | 177.06 |
| EV / FCF | 251.93 |
Financial Position
The company has a current ratio of 6.49, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.49 |
| Quick Ratio | 6.38 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 51.82% and return on invested capital (ROIC) is 43.93%.
| Return on Equity (ROE) | 51.82% |
| Return on Assets (ROA) | 33.09% |
| Return on Invested Capital (ROIC) | 43.93% |
| Return on Capital Employed (ROCE) | 53.38% |
| Revenue Per Employee | 1.61M |
| Profits Per Employee | 872,856 |
| Employee Count | 132 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 4.20 |
Taxes
In the past 12 months, Pro Medicus has paid 48.10 million in taxes.
| Income Tax | 48.10M |
| Effective Tax Rate | 29.45% |
Stock Price Statistics
The stock price has increased by +37.42% in the last 52 weeks. The beta is 0.40, so Pro Medicus's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +37.42% |
| 50-Day Moving Average | 297.24 |
| 200-Day Moving Average | 275.99 |
| Relative Strength Index (RSI) | 26.07 |
| Average Volume (20 Days) | 135,894 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pro Medicus had revenue of AUD 212.98 million and earned 115.22 million in profits. Earnings per share was 1.10.
| Revenue | 212.98M |
| Gross Profit | 212.67M |
| Operating Income | 157.79M |
| Pretax Income | 163.31M |
| Net Income | 115.22M |
| EBITDA | 158.12M |
| EBIT | 157.79M |
| Earnings Per Share (EPS) | 1.10 |
Balance Sheet
The company has 210.66 million in cash and 2.26 million in debt, giving a net cash position of 208.40 million or 1.99 per share.
| Cash & Cash Equivalents | 210.66M |
| Total Debt | 2.26M |
| Net Cash | 208.40M |
| Net Cash Per Share | 1.99 |
| Equity (Book Value) | 256.96M |
| Book Value Per Share | 2.46 |
| Working Capital | 236.96M |
Cash Flow
In the last 12 months, operating cash flow was 111.33 million and capital expenditures -439,000, giving a free cash flow of 110.89 million.
| Operating Cash Flow | 111.33M |
| Capital Expenditures | -439,000 |
| Free Cash Flow | 110.89M |
| FCF Per Share | 1.06 |
Margins
Gross margin is 99.85%, with operating and profit margins of 74.09% and 54.10%.
| Gross Margin | 99.85% |
| Operating Margin | 74.09% |
| Pretax Margin | 76.68% |
| Profit Margin | 54.10% |
| EBITDA Margin | 74.24% |
| EBIT Margin | 74.09% |
| FCF Margin | 52.07% |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 0.21%.
| Dividend Per Share | 0.60 |
| Dividend Yield | 0.21% |
| Dividend Growth (YoY) | 37.50% |
| Years of Dividend Growth | 9 |
| Payout Ratio | 42.63% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.20% |
| Earnings Yield | 0.41% |
| FCF Yield | 0.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pro Medicus has an Altman Z-Score of 170.27 and a Piotroski F-Score of 4.
| Altman Z-Score | 170.27 |
| Piotroski F-Score | 4 |